Share price: 129.50p

Year End 2012 Prelim Statement

13th March 2013

Solid overall 2012 performance – Cello Health continued growth; Cello Consumer H2 recovery

Cello Group plc (AIM:CLL, “Cello” or “the Group”), the insight and strategic marketing group, today announces its final audited results for the year to 31 December 2012.

Prelim Statement 2012

Contact Us

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150